Published in AIDS Weekly, March 10th, 2008
"In this study, we tested whether HRF might have much broader activity against other organisms whose pathogenesis is linked to NF-kappa B activation. Specifically, we tested the effects of HRF on the NF-kappa B-mediated responses of primary macrophages to HIV-1 or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.